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Risk factors for breast cancer can be allocated to one of four
major groups: family history/genetic, reproductive/hormonal,
proliferative benign breast disease and mammographic
density. These four factors have now been thoroughly studied,
and accurate quantitative estimates for the risk are now
available for many of them. The most useful summary comes
from the Oxford collaboration, which has now produced a
series of papers estimating the risk associated with individual
factors [1-3]. In terms of family history, compared with a
woman with no affected relatives, a single affected first-
degree relative roughly doubles the risk; two such individuals
triple the risk, and three or more quadruple the risk. The age
at which cancer occurs in a mother or sister also affects risk,
with young age at onset leading to higher risk; risk is
approximately threefold for onset under age 40 years, twofold
for age 40 to 50 years and 1.5-fold for age 50 to 65 years,
and there is little increase for older ages unless there are
multiple affected cases. This is further complicated by the
fact that the relative risk is greatest when the woman herself
is young, especially if the family member had early onset
cancer, and diminishes as the women ages and does not
develop cancer. A relative with bilateral breast cancer can be
treated as having two affected relatives for the purposes of
these calculations.
Reproductive factors are also well established risk factors,
with age at first childbirth being the most well known.
Nulliparous women have similar risk to that in women whose
first child was born when they were aged 30 years, with a
later first birth giving rise to a higher risk (especially within
5 years after delivery) and women giving birth when they were
young at lower risk. The relative risk decreases by about 3%
for every year younger (maternal age) that childbirth occurs,
so that a woman whose first child was born when she was
aged 20 years has about a 30% lower relative risk than a
woman whose first child was born when she was aged 30
years. Because the absolute lifetime risk for breast cancer is
about 10%, this translates into a 3% lower absolute risk.
Subsequent births reduce relative risk by about 7% per birth,
but these also have a similar but weaker link to age at first
childbirth.
Breast feeding is protective, but substantial periods of breast
feeding are needed to have a material impact, and the relative
risk is estimated to decrease by 4.3% per cumulative year of
breast feeding, so several cumulative years are needed
before this factor becomes appreciable.
An early age at beginning of menstruation increases risk (4%
per year), as does late age at menopause (3% per year).
Hence, increased duration of ovulation is a risk factor, and
this unifies the above factors because single pregnancy and
lactation suppress ovulation while they occur. Use of
hormone replacement therapy, especially combined
oestrogen and progesterone preparations, also increase risk
by up to 5% per year of use, but only in current users, and the
risk returns to baseline levels within a year of stopping use
[4]. Certain types of benign breast disease increase risk as
well. Ductal carcinoma in situ (DCIS) is considered to be a
precursor lesion to cancer and not benign, and the risk for
invasive disease is very high. In contrast, lobular carcinoma in
situ is considered benign and indicative of a field change, so
that subsequent cancers can arise anywhere in either breast,
as opposed to DCIS, in which subsequent cancer more
frequently occurs in the same quadrant as the DCIS. In any
case, lobular carcinoma in situ confers an approximately 10-
fold relative risk. Atypical ductal or lobular hyperplasia confers
a relative risk of about 4 to 5, whereas proliferative hyper-
plasia or other benign lesions without atypia (for instance,
intraductal papillomatosis) roughly double the risk. Non-
proliferative lesions, including a sizeable portion of fibro-
adenomas and cysts, do not increase risk.
Being obese increases risk in postmenopausal women,
whereas being tall and drinking alcohol increases risk at all
ages. Obesity is well known to be related to increased
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oestrogen levels in postmenopausal women. The other two
factors (alcohol and height) undoubtedly are also related to
hormones or growth factors, but the mechanisms are not well
understood.
Mammographic density is probably the single most important
factor in terms of population attributable risk. Almost 5% of
the population has more than 75% of the breast covered by
density on a mammogram, and they have about a fivefold
increased risk compared with women with less than 10%
density [5]. Women with 50% to 75% of the mammogram
covered by opaque tissue also have about a twofold to
threefold increase in risk and comprise about 14% of the
population. Mammographic density can be rapidly and reliably
estimated visually from a mammogram, as indicated by the
large Breast Cancer Consultation study of 81,777 women
[6], in which simple Breast Imaging Reporting and Data
Systems (BIRADS) categories yielded risk prediction
accuracy similar to that of the Gail model. The challenge is to
combine these factors effectively.
Computer-assisted approaches appear to yield slightly more
accurate and reproducible readings, but they are currently
rather time consuming. This will undoubtedly change, how-
ever, when digital mammography becomes more widespread,
so that digitization of films will not be necessary.
Less is known about the possible interactions between these
factors, and virtually nothing is known about how different
factors influence the risks for different types of breast cancer
(for example, oestrogen receptor positive versus negative
tumours). However, risk factors appear to be largely indepen-
dent, and this facilitates the building of a model to predict risk
in individuals. Previous models have focused on either
nongenetic factors [7], in which important factors relating to
genetic risk are not considered, or strictly familial factors [8],
in which the modifying effect of other factors is not included.
Our own model [9] incorporates the best features of both of
these models and was found to be a more accurate predictor
of risk in a genetic counselling clinic [10].
Mammographic density has not been included in any of these
models, although it is currently the one risk factor with the
largest population attributable risk [5]. There is an urgent
need to learn how best to combine this information with other
factors and to learn how best to counsel women about their
risk and the need for preventative actions.
Even with all of these factors, our ability to determine who will
develop breast cancer and who will not is limited, and
improving risk determination is important in targeting
prevention activities and screening. It remains to be seen how
much further prediction can be derived from identifying rare
and low-risk genetic polymorphisms. In my view, the greatest
likelihood of improved prediction will come from phenotypic
markers based on hormone profiles, methylation status (both
in serum and breast biopsies) and possibly further refinement
of mammographic features.
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